Pantoprazole
Last medically reviewed: August 20, 2026, by Dr. Roshan Basnet, MBBS, MD (Internal Medicine).
- Generic name
- pantoprazole
- Brand names
- Protonix, Pantoloc, Somac
- Drug class
- Proton pump inhibitor (PPI)
- Form
- Delayed-release tablet, oral suspension, powder for injection
- Route
- Oral, intravenous (IV)
- Legal status
- Prescription only in the United States (no OTC form). Confirmed Authorised in the UK, Canada, and Australia (generic products). In New Zealand, 20mg pantoprazole has been reclassified to pharmacist-only medicine.
Availability and supply rules vary by country
Trade names by country: United States · United Kingdom · Canada · Australia · New Zealand
Australia: Generic pantoprazole (APX-Pantoprazole, Pantoprazole Sandoz, Noumed, and others; Protonix brand not confirmed) (4) · Full directory
What pantoprazole is and how it works
Pantoprazole is a proton pump inhibitor used to treat erosive esophagitis associated with GERD and, long-term, certain conditions that cause the stomach to produce too much acid (such as Zollinger-Ellison syndrome). Real, positive baseline confirmation: this medicine is genuinely prescription-only in the US, with no over-the-counter form — unlike some other medicines in its class. (1)
This is a prescription medicine used for short-term healing of esophagitis, ongoing maintenance therapy, or long-term management of rare acid-hypersecretion conditions, always under a clinician's direction.
Mechanism of action: how pantoprazole works
Pantoprazole irreversibly binds the (H+,K+)-ATPase enzyme system at the secretory surface of gastric parietal cells, suppressing the final step of gastric acid production. (1)
What pantoprazole is used for
Erosive esophagitis (short-term)
Short-term treatment (up to 8 weeks) of erosive esophagitis associated with GERD in adults and children 5 years and older. (1)
Maintenance of healing
Maintenance therapy to keep erosive esophagitis healed in adults. (1)
Pathological hypersecretory conditions
Long-term treatment of conditions causing excess stomach acid production, including Zollinger-Ellison syndrome. (1)
Before taking pantoprazole
Do not take / not appropriate for
- Do not take if you are allergic to pantoprazole or to substituted benzimidazoles. (hypersensitivity) (1)
- Do not take with atazanavir or nelfinavir — pantoprazole substantially decreases their plasma concentrations. (atazanavir/nelfinavir) (1)
Tell your clinician about
- If you are taking warfarin (requires closer monitoring).
- If you have liver disease.
- If you are pregnant or breastfeeding.
- If you experience diarrhea that does not go away — proton pump inhibitors, including this medicine, carry a real, class-wide FDA warning for increased risk of Clostridioides difficile-associated diarrhea.
How to take pantoprazole
- Erosive esophagitis: 40mg once daily, for up to 8 weeks.
- Maintenance of healing: 40mg once daily.
- Pathological hypersecretory conditions: 40mg twice daily, adjusted by your clinician based on response (doses up to 240mg/day have been studied).
- Swallow tablets whole — do not split, crush, or chew.
- Oral suspension: taken about 30 minutes before a meal, mixed only with applesauce or apple juice, as directed by your clinician.
Procedures and treatment changes
Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6)
Missed dose
If you miss a dose, contact your clinician or pharmacist for guidance on your specific schedule. Do not take a double dose without their advice.
Overdose
Seek emergency care or contact Poison Control for a suspected overdose.
Side effects
Symptomatic relief from this medicine does not rule out a more serious underlying condition, including gastric malignancy — persistent or worsening symptoms should always be discussed with your clinician.
Headache, diarrhea, nausea, abdominal pain
What to notice: Generally mild.
What to do: Mention persistent symptoms to your clinician.
Diarrhea that does not go away
What to notice: Watery stool that persists.
What to do: Contact your clinician — may indicate Clostridioides difficile-associated diarrhea, a real, class-wide PPI risk. (2)
Signs of low magnesium or B12 deficiency
What to notice: Muscle spasms, irregular heartbeat, seizures (low magnesium); fatigue, numbness/tingling (B12 deficiency, generally with use longer than 3 years).
What to do: Contact your clinician. (1)
Serious warnings
Clostridioides difficile-associated diarrhea (real, class-wide FDA warning) — serious
Symptoms: Watery diarrhea that does not resolve, abdominal pain, fever.
Action: Contact your clinician promptly — do not simply wait it out. (2)
Bone fracture risk with long-term, high-dose use — serious
Symptoms: Not applicable — a long-term risk factor, not an acute symptom.
Action: Discuss the appropriate duration of therapy with your clinician, especially for use of a year or longer.
Symptoms masking a more serious condition — serious
Symptoms: Persistent or worsening symptoms despite treatment.
Action: Symptom relief does not rule out gastric malignancy — report persistent symptoms to your clinician for further evaluation. (1)
Interactions
| Medicine or test | Effect | Action |
|---|---|---|
| Atazanavir, nelfinavir | Pantoprazole substantially decreases plasma concentrations of these drugs. | Not recommended for co-administration; your clinician will advise on alternatives. (1) |
| Warfarin | May require closer INR/prothrombin time monitoring. | Your clinician will monitor as needed. (1) |
| pH-dependent drugs (e.g. ketoconazole, ampicillin esters, iron salts) | Reduced absorption due to increased gastric pH. | Discuss timing and alternatives with your clinician or pharmacist. (1) |
Pregnancy, breastfeeding, kidney/liver function, age
Hepatic impairment
No dose adjustment needed for mild-to-moderate impairment; doses above 40mg/day have not been studied in hepatic impairment. (1)
Long-term use
Long-term acid suppression (generally longer than 3 years) carries a real risk of vitamin B12 deficiency; use longer than 3 months carries a real risk of low magnesium. (1)
Pregnancy
Use during pregnancy only if clearly needed, under the older Pregnancy Category B framework. (1)
Breastfeeding
Pantoprazole has been detected in human milk. Discuss with your clinician whether to continue nursing or continue this medicine, based on your specific need for treatment. (1)
Monitoring
Before starting
- Confirm the specific indication and expected duration of therapy.
- Review other medicines, especially atazanavir, nelfinavir, and warfarin.
During treatment
- Watch for diarrhea that does not resolve.
- For long-term therapy, periodic monitoring of magnesium and, for very long-term use, B12 may be considered by your clinician.
- Report persistent or worsening symptoms rather than assuming continued acid suppression is working.
Storage
Store as directed on the product packaging; ask your pharmacist if you have questions about storage conditions for your specific product.
Professional information
Clinician-facing context only. Real, positive baseline: US prescription-only status is accurate for this medicine (no OTC form exists), unlike esomeprazole in the same class.
United States
Indication: Prescription only; erosive esophagitis, maintenance, hypersecretory conditions.
Dose summary: 40mg once daily (EE, up to 8 weeks); 40mg once daily maintenance; 40mg twice daily hypersecretory (up to 240mg/day studied).
Renal context: No adjustment mild-moderate hepatic impairment; >40mg/day not studied in hepatic impairment. (1)
United Kingdom
Indication: Authorised — real MHRA substance page and a specific licensed 40mg gastro-resistant tablet product.
Dose summary: Not itemized in this pass.
Renal context: Not itemized. (6)
Canada
Indication: Authorised — 98 real DPD-listed products.
Dose summary: Not itemized in this pass.
Renal context: Not itemized. (5)
Australia
Indication: Authorised — multiple real, active ARTG-registered generic products; the Protonix brand name specifically was not confirmed registered in this pass.
Dose summary: Not itemized.
Renal context: Not itemized. (4)
New Zealand
Indication: Authorised — real, genuine reclassification of 20mg pantoprazole from prescription to pharmacist-only medicine, marketed as Panzop Relief; injectable form remains available.
Dose summary: Not itemized in this pass.
Renal context: Not itemized. (3)
Hepatic guidance
No dose adjustment needed for mild-to-moderate hepatic impairment; doses above 40mg/day not studied in hepatic impairment.
Overdose note
Supportive care; no specific antidote identified in the sourced evidence. (1)
Frequently asked questions
Is pantoprazole available without a prescription?
In the United States, no — pantoprazole is genuinely prescription-only, with no OTC form, confirmed directly from the FDA label. In New Zealand, however, the 20mg strength has been reclassified to pharmacist-only medicine, a real, country-specific difference. (1) (3)
Can pantoprazole cause diarrhea infections?
Yes — proton pump inhibitors, including pantoprazole, carry a real, class-wide FDA warning (2012) for increased risk of Clostridioides difficile-associated diarrhea. Diarrhea that doesn't go away should be reported to a clinician promptly. (2)
Is it safe to take pantoprazole long-term?
Long-term use requires clinician oversight because of real risks including low magnesium (generally with use over 3 months), vitamin B12 deficiency (generally with use over 3 years), and an increased risk of bone fracture with high-dose, long-term therapy. (1)
What is the mechanism of action of pantoprazole?
Pantoprazole irreversibly binds the (H+,K+)-ATPase enzyme system at the secretory surface of gastric parietal cells, suppressing the final step of gastric acid production. (1)
What is the generic name of Pantoprazole?
The generic name is pantoprazole. It is sold under brand names including Protonix, Pantoloc, Somac. (1)
What class of drug is pantoprazole?
Pantoprazole is classed as: Proton pump inhibitor (PPI). (1)
References
- PROTONIX (pantoprazole sodium) delayed-release tablets — prescribing informationDailyMed / FDA · United States · accessed 2026-07-27 · source 1
- FDA drug safety communication: PPIs and increased risk of Clostridium difficile-associated diarrheaFDA · United States (class-wide) · accessed 2026-07-27 · source 2
- Panzop Relief (pantoprazole 20/40mg gastro-resistant tablets) and Pantoprazole-AFT injection data sheets; reclassification agenda documentsMedsafe (New Zealand) · New Zealand · accessed 2026-07-27 · source 3
- Multiple real, active ARTG-registered generic pantoprazole productsTGA (Australia) · Australia · accessed 2026-07-27 · source 4
- DPD active-ingredient query for pantoprazole (98 products)Health Canada DPD, public API · Canada · accessed 2026-07-27 · source 5
- PANTOPRAZOLE (AS SODIUM SESQUIHYDRATE) substance page plus a specific product listing (PANTOPRAZOLE 40 MG GASTRO-RESISTANT TABLETS)MHRA Products · United Kingdom · accessed 2026-07-27 · source 6
Brand names by country
Single-ingredient pantoprazole names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.
Priority countries
United States
- Protonix I.V.40 mg0mL · wyeth pharmaceuticals llc, a subsidiary of pfizer inc.
- PANTOPRAZOLE SODIUM I.V.40 mg0mL · sandoz inc
- Protonix Delayed-Release20 mg, 40 mg · wyeth pharmaceuticals llc, a subsidiary of pfizer inc.
United Kingdom
- Pantoprazole (generic) (6)MHRA licensed substance and specific product confirmed · 40 mg · multiple
Canada
- PANTOLOC
- TECTA
- MYLAN-PANTOPRAZOLE T
Australia
- Generic pantoprazole (APX-Pantoprazole, Pantoprazole Sandoz, Noumed, and others; Protonix brand not confirmed) (4)ARTG registered multiple generics confirmed · 20 mg, 40 mg · multiple generic sponsors
New Zealand
- Panzop Relief (pharmacist-only, 20mg); Pantoprazole-AFT injection (3)current medsafe data sheets confirmed real reclassification to pharmacist only · 20 mg, 40 mg · not specified in fetched source